Skip to main content


Health

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.
810 of 1797




Newsletter Sign Up



Daily Readings

Reading 1, Numbers 12:1-13
Miriam, and Aaron too, criticised Moses over the Cushite woman ... Read More

Psalm, Psalms 51:3-4, 5-6, 6-7, 12-13
For I am well aware of my offences, my sin is constantly in ... Read More

Gospel, Matthew 14:22-36
And at once he made the disciples get into the boat and go on ... Read More

Saint of the Day

August 4 Saint of the Day

St. John Vianney
August 4: St. John Vianney, Priest (Patron of priests) Feast day - August ... Read More